Methodology

All entries for: AniMusCure Inc.

September 8, 2025

AniMusCure Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of Duchenne muscular dystrophy (DMD)

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top